Loading the company…
Loading the company…
Families: Debridement & negative-pressure wound therapy.
All companies · Product and company coverage
In 2025, Medela reported engagement with 38 surgeons and other clinicians in the states MedaRep covers, worth $20K in consulting, speaking, meals and travel for its device products, the most in Illinois ($6,000 to 1). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Illinois ($6,000, 1 engaged), New York ($5,746, 4 engaged), Arizona ($3,683, 5 engaged), Minnesota ($2,500, 1 engaged), North Carolina ($1,500, 1 engaged).
In the last ten years FDA made 6 decisions for Medela (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2018 (2). The latest was on 2023-07-07.
| Family | Decisions on record |
|---|---|
| Debridement & negative-pressure wound therapy | 13 |
| Invia Foam Dressing Kits With FitPad, Invia Motion Negative Pressure Wound Therapy System (Invia Motion - Endure, Invia Motion 120 days, Invia Motion 60 days, Invia Motion 30 days, Invia Motion 15 days, Invia Motion 7 days), Invia Liberty Negative Pressure Wound Therapy System, Invia Gauze Dressing Kits with FitPad |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Medela.